Date: 2014-08-20
Type of information: Collaboration agreement
Compound:
Company: The University of Nottingham (UK) China Resources Pharmaceutical Group (CRPG) (China)
Therapeutic area:
Type agreement:
Action mechanism:
Disease:
Details: * On August 20, 2014, the University of Nottingham has signed a wide-reaching memorandum of understanding with China Resources Pharmaceutical Group (CRPG) in Beijing, which will see close collaboration between the two organisations in a range of areas. Under the agreement, which was coordinated by the University’s Asia Business Centre, CRPG will partner with Nottingham in a number of ways, including training, staff exchanges, student internships and research and development. In addition, CRPG has built a pharmaceutical industrial park in Beijing which has been funded by the Chinese government. The company will work with the University to develop this park by learning from the BioCity model, a Nottingham based bioscience incubation centre, of which the University is a co-founder. The University of Nottingham already has an existing relationship with CPRG. It worked with the company in 2013 to design and deliver a two-week long executive training course for the senior managers of its subsidiary China Resources Pharmaceutical Commercial Group. Earlier this year, six students from the University’s School for Contemporary Chinese Studies went to China to intern with different sub-companies within the China Resources Group. With revenue of £5.2 billion, CPRG is one of the top three pharmaceutical companies in China, and is one of the seven core business units of its parent company, China Resources (Holding) Co., Ltd. Dating back to 1938, and with an annual turnover of over £38 billion and more than 420,000 employees, China Resources is one of the longest established and largest central government owned enterprises in the country. CRPG is ranked 144th in the latest Fortune Global 500 list.
Financial terms:
Latest news:
